Co-Diagnostics, Inc.

NasdaqCM:CODX 株式レポート

時価総額:US$39.7m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Co-Diagnostics 過去の業績

過去 基準チェック /06

Co-Diagnosticsの収益は年間平均-28.6%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間8.7% 4.8%割合で 増加しています。

主要情報

-28.6%

収益成長率

-23.6%

EPS成長率

Medical Equipment 業界の成長8.9%
収益成長率4.8%
株主資本利益率-49.6%
ネット・マージン-582.4%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Here's Why We're Watching Co-Diagnostics' (NASDAQ:CODX) Cash Burn Situation

Jun 14
Here's Why We're Watching Co-Diagnostics' (NASDAQ:CODX) Cash Burn Situation

One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%

May 18
One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%

A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Apr 14
A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Co-Diagnostics: Hold Thesis Remains Well Intact

Sep 07

Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes

Aug 11

Co-Diagnostics spikes on shipments of monkeypox test

Jul 11

Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Jul 06
Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Co-Diagnostics: Well Priced, Long-Term Value Remains Too Distant

Jun 21

Co-Diagnostics: Where's Eikon?

Apr 03

Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Mar 28
Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Co-Diagnostics: Swinging For The Fences

Jan 24

Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

Dec 28
Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

Why Co-Diagnostics Is A Solid Covid-19 Play

Aug 19

Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Aug 14
Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Co-Diagnostics gets CE marking for direct saliva SARS-CoV-2 test

Jun 18

Co-Diagnostics: No One-Hit Wonder

Jun 04

This Just In: Analysts Are Boosting Their Co-Diagnostics, Inc. (NASDAQ:CODX) Outlook for This Year

May 18
This Just In: Analysts Are Boosting Their Co-Diagnostics, Inc. (NASDAQ:CODX) Outlook for This Year

収支内訳

Co-Diagnostics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqCM:CODX 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 247-392124
31 Dec 237-352123
30 Sep 235-432222
30 Jun 237-382221
31 Mar 2312-322119
31 Dec 2234-142217
30 Sep 2253152015
30 Jun 2278282216
31 Mar 22101402617
31 Dec 2198372515
30 Sep 21105422514
30 Jun 219646219
31 Mar 219351155
31 Dec 207542133
30 Sep 20482892
30 Jun 20261072
31 Mar 202-651
31 Dec 190-651
30 Sep 190-651
30 Jun 190-651
31 Mar 190-651
31 Dec 180-651
30 Sep 180-651
30 Jun 180-851
31 Mar 180-841
31 Dec 170-741
30 Sep 170-631
30 Jun 170-311
31 Mar 170-211
31 Dec 160-211
30 Sep 160-211
31 Dec 150-211

質の高い収益: CODXは現在利益が出ていません。

利益率の向上: CODXは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: CODXは利益が出ておらず、過去 5 年間で損失は年間28.6%の割合で増加しています。

成長の加速: CODXの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: CODXは利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 2.4% ) と比較することは困難です。


株主資本利益率

高いROE: CODXは現在利益が出ていないため、自己資本利益率 ( -49.63% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘